How close are we to a cure?

How close are we to a cure?

July 18, 2026 · 58 min · Season 1 · Episode 66

About this episode

This episode discusses the latest advancements in Parkinson's research and treatments with guest David Dexter from Parkinson's UK.

Guest: David Dexter, Director of Research, Parkinson’s UK There’s a real sense of optimism in Parkinson’s research right now! In this episode we’re asking whether we’re closer than ever to treatments that can slow, stop, or even reverse the disease. David Dexter joins us to discuss exciting developments including breakthrough stem cell research, the promising results from a drug called Syntara , why reducing brain inflammation could be a game changer, and how Parkinson’s UK decides which research to back. We also chat to Yorkshireman Andy Cassy who’s had millions of Stem Cells “planted” in his brain. Two years on from his 12 hour operation, is it working? We also explore whether stress affects Parkinson’s, if an apple a day really can help keep the neurologist away, the science behind fatigue and NAD+ a cheap energy boosting supplement We finish with a fun quick-fire round to discover the person behind the scientist. Plus- how Dave managed to skip into Wimbledon for semifinals day. Parkinson’s UK Research https://www.parkinsons.org.uk/research Par-Con 2026 https://www.parkinsons.org.uk/community/par-con Symprove https://shop.parkinsons.org.uk/pages/partner-symprove NAD+…

People in this episode

Hosts: Dave Clark, Kuhan

Guest: David Dexter

Topics covered

Keywords

Mentioned in this episode

Organizations: Parkinson’s UK, Symprove

Products: Syntara, NAD+

Places: Wimbledon

More episodes of 2 Parkies in a Pod: a Parkinson's Podcast

Explore listener stats, chart rankings, contacts and more on the 2 Parkies in a Pod: a Parkinson's Podcast podcast page.